Classification and Detection of Mesothelioma Cancer Using Feature Selection-Enabled Machine Learning Technique.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
06
2022
revised:
30
06
2022
accepted:
14
07
2022
entrez:
8
8
2022
pubmed:
9
8
2022
medline:
10
8
2022
Statut:
epublish
Résumé
Cancer of the mesothelium, sometimes referred to as malignant mesothelioma (MM), is an extremely uncommon form of the illness that almost always results in death. Chemotherapy, surgery, radiation therapy, and immunotherapy are all potential treatments for multiple myeloma; however, the majority of patients are identified with the disease at an advanced stage, at which time it is resistant to these therapies. After obtaining a diagnosis of advanced multiple myeloma, the average length of time that a person lives is one year after hearing this news. There is a substantial link between asbestos exposure and mesothelioma (MM). Using an approach that enables feature selection and machine learning, this article proposes a classification and detection method for mesothelioma cancer. The CFS correlation-based feature selection approach is first used in the feature selection process. It acts as a filter, selecting just the traits that are relevant to the categorization. The accuracy of the categorization model is improved as a direct consequence of this. After that, classification is carried out with the help of naive Bayes, fuzzy SVM, and the ID3 algorithm. Various metrics have been utilized during the process of measuring the effectiveness of machine learning strategies. It has been discovered that the choice of features has a substantial influence on the accuracy of the categorization.
Identifiants
pubmed: 35937383
doi: 10.1155/2022/9900668
pmc: PMC9348925
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9900668Informations de copyright
Copyright © 2022 M. Shobana et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Cancer Treat Rev. 2015 Jan;41(1):27-34
pubmed: 25467107
Comput Math Methods Med. 2021 Oct 20;2021:4019358
pubmed: 34721657
Methods Inf Med. 2007;46(3):324-31
pubmed: 17492119
Int J Neural Syst. 2016 Nov;26(7):1650025
pubmed: 27478060
Comput Methods Programs Biomed. 2017 Jul;146:11-24
pubmed: 28688481
Comput Math Methods Med. 2022 Apr 8;2022:6841334
pubmed: 35432588
J Healthc Eng. 2021 Oct 27;2021:1233166
pubmed: 34745488
ScientificWorldJournal. 2014 Mar 23;2014:536434
pubmed: 24790571
Genom Data. 2016 Feb 23;8:4-15
pubmed: 27081632